Immunocore Holdings Ltd Cash Flow Reinvestment Rate
Immunocore Holdings Ltd cash flow reinvestment rate. Immunocore Holdings Ltd (IMCR) has a Cash Flow Reinvestment Rate of 1.19x as of June 2025, reinvesting $30.83 Million (capex $414.00K plus investments $-30.41 Million) from operating cash flow of $25.96 Million. Explore IMCR cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Immunocore Holdings Ltd (2013–2024)
Cash flow reinvestment rate of Immunocore Holdings Ltd from 2013 to 2024. Historical reinvestment intensity for Immunocore Holdings Ltd across 4 annual periods. Explore capital reinvestment ratio of Immunocore Holdings Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Immunocore Holdings Ltd Cash Flow Reinvestment Rate by Year (2013–2024)
Immunocore Holdings Ltd cash flow reinvestment rate by year from 2013 to 2024. Year-by-year capital reinvestment analysis for Immunocore Holdings Ltd. For the full cash flow conversion analysis, see cash flow conversion of Immunocore Holdings Ltd.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 13.83x | $360.30 Million | $26.06 Million | $5.17 Million | ▲ +254.3% |
| 2023 | 3.90x | $9.08 Million | $2.33 Million | $4.29 Million | ▲ +7551.0% |
| 2014 | 0.05x | $2.03 Million | $39.79 Million | $2.03 Million | ▼ -0.8% |
| 2013 | 0.05x | $579.08K | $11.26 Million | $579.08K | — |